Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Rhabdomyosarcoma 1Peritoneal Neoplasms 1Neurofibrosarcoma 1Neoplasms, Connective and Soft Tissue 1Myosarcoma 1Liposarcoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Histiocytoma 1Fibrosarcoma 1Chondrosarcoma 1

Interventions

pazopanib 2temsirolimus 1sapanisertib 1liposomal doxorubicin 1lentiviral minigene vaccine of COVID-19 coronavirus 1Sunitinib 1Nivolumab 1Methotrexate 1Immune Checkpoint Inhibitors 1Imatinib Mesylate 1Ifosfamide 1HhAntag691 1Epirubicin 1Doxorubicin 1Docetaxel 1Dacarbazine 1Cisplatin 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Histiocytoma, Malignant Fibrous × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all
NCT01883518 2019-11-20

ADCVCTAST

N.N. Petrov National Medical Research Center of Oncology

Phase 1/2 Unknown
48 enrolled
Sarcoma

Chondrosarcoma, Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Myosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Neoplasms, Connective and Soft Tissue, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡